Highlights Applied BioCode Corporation

Equities

6598

KYG0488D1051

End-of-day quote Taiwan S.E. Other stock markets 03:30:00 07/06/2024 am IST			5-day change	1st Jan Change
20 ^TWD	+0.76%		-0.74%	-20.95%

15/04	Applied BioCode Announces the Launch of the STI + Resistance Panel Assay for Research Use Only	CI
21/03	Applied BioCode Announces CEO Changes	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Applied BioCode Announces the Launch of the STI + Resistance Panel Assay for Research Use Only	15/04	CI
Applied BioCode Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	14/03	CI
Applied BioCode Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11	CI
Applied BioCode Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	28/23/28	CI
Applied Biocode Corporation Announces the Launch of the Fungal Panel Assay for Research Use	12/23/12	CI
Applied BioCode Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	12/23/12	CI
Applied BioCode Corporation Announces Distribution Agreement with Medline Industries	08/23/08	CI
Applied BioCode Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	22/23/22	CI
Applied BioCode Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	22/23/22	CI
Applied Biocode Corporation Announces Revenue Results for the Fourth Quarter and Full Year of 2022	27/23/27	CI
Applied BioCode Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	11/22/11	CI
Applied BioCode Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	29/22/29	CI
Applied BioCode Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	13/22/13	CI
Applied BioCode Corporation Reports Earnings Results for the Full Year Ended December 31, 2021	28/22/28	CI
Applied BioCode Announces Exclusive Partner Distribution Agreement with Hardy Diagnostics	14/22/14	CI
Applied BioCode Obtains Emergency Use Authorization for CoV-2 Flu Plus Assay	16/21/16	CI
Applied BioCode Launches 28 New Fungal Analyte Specific Reagents in the US	23/21/23	CI
Applied BioCode Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	12/21/12	CI
Applied Biocode Corporation Reports Earnings Results for the First Quarter Ended March 31, 2021	13/21/13	CI
Applied Biocode Corporation Reports Earnings Results for the Full Year Ended December 31, 2020	29/21/29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Applied BioCode Corporation

Equities

6598

KYG0488D1051

Highlights

Filters